Optinose

About Optinose

Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. Their mission is to improve the quality of life for patients by becoming the leading specialty pharmaceutical company dedicated to innovative products that become the standard of care for ENT and allergy-related conditions.

Products & Services

XHANCE (fluticasone propionate):A lead product with potential to become an important treatment option for patients with unmet needs, using Bi-Directional Exhalation Delivery Systems to deliver a potent steroid deep into the nasal passages.

ONZETRA Xsail:A product offered by Optinose, though specific details are not provided in the content.

Exhalation Delivery Systems (EDS):A unique drug delivery technology including liquid and powder delivery devices, aimed at delivering medication to hard-to-reach areas of the nasal passages for ENT and allergy treatments.

Specialties

Ear, Nose, and Throat (ENT) treatments Allergy treatments Bi-Directional Exhalation Delivery Systems (EDS) Innovative drug delivery technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 55000000 MR: - FA: $55 million FAN: 55000000	D: 2024-05-09 FD: 2024-05-09	2 investors

Registered Direct Offering Latest

2024-05-09

$55.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Optinose Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised